Figure 6.
Effects of hesperidin on the reactive oxygen species (ROS) (A) and malondialdehyde (MDA) (B) levels, superoxide dismutase (SOD) activity, (C) and reduced glutathione (GSH) levels (D) in the amygdala and hippocampus of control rats (Cont), streptozotocin (STZ)-induced diabetic rats (DM), diabetic rats treated with hesperidin at low and high (50, 150 mg/kg) doses, and diabetic rats treated with the Nrf2 activator tert-butylhydroquinone (TBHQ) (25 mg/kg). The results are presented as the mean ± S.E.M., n = 7. *p < 0.05, **p < 0.01, ***p < 0.001, vs. Cont group; #p < 0.05, ##p < 0.01, ###p < 0.001, vs. DM group.